The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-5-((7-Chloro-10-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-3-methyl-1-oxo-6-(1,3,5-trimethyl-1H-pyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)methyl)furan-2-carboxylic Acid ID: ALA4521315
PubChem CID: 118394699
Max Phase: Preclinical
Molecular Formula: C35H36Cl2N4O5
Molecular Weight: 663.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(OCCCc2c3n(c4c(-c5c(C)nn(C)c5C)c(Cl)ccc24)C[C@@H](C)N(Cc2ccc(C(=O)O)o2)C3=O)cc(C)c1Cl
Standard InChI: InChI=1S/C35H36Cl2N4O5/c1-18-14-24(15-19(2)31(18)37)45-13-7-8-25-26-10-11-27(36)30(29-21(4)38-39(6)22(29)5)32(26)41-16-20(3)40(34(42)33(25)41)17-23-9-12-28(46-23)35(43)44/h9-12,14-15,20H,7-8,13,16-17H2,1-6H3,(H,43,44)/t20-/m1/s1
Standard InChI Key: DBLYUECFQBVGCM-HXUWFJFHSA-N
Molfile:
RDKit 2D
46 51 0 0 0 0 0 0 0 0999 V2000
2.6606 -14.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6595 -15.6404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3675 -16.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3658 -14.4120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0744 -14.8172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0746 -15.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8533 -15.8886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9528 -14.4124 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.3602 -13.5975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0198 -13.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7650 -12.3388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9477 -12.3412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6977 -13.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2433 -11.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8454 -16.7029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5491 -17.1184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5411 -17.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2448 -18.3510 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9212 -13.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2369 -19.1681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5237 -19.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5154 -20.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2197 -20.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9337 -20.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9385 -19.5783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2128 -21.6166 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.6389 -20.8064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8036 -20.7845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8529 -14.5641 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3340 -15.2260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1432 -15.1408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4777 -14.3947 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9967 -13.7328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1811 -13.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7978 -13.3654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6228 -15.8025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2928 -14.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7040 -15.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3760 -15.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9853 -16.3877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6916 -15.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5186 -15.1778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4394 -16.3060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4348 -17.1197 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1251 -15.8615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3296 -12.9865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 30 2 0
29 5 1 0
1 8 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 9 1 0
4 9 1 0
11 14 1 0
7 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
13 19 1 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
24 27 1 0
22 28 1 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
10 35 1 0
31 36 2 0
32 37 1 0
37 38 1 0
38 39 2 0
39 40 1 0
40 41 2 0
41 42 1 0
42 38 1 0
41 43 1 0
43 44 2 0
43 45 1 0
33 46 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 663.60Molecular Weight (Monoisotopic): 662.2063AlogP: 7.93#Rotatable Bonds: 9Polar Surface Area: 102.73Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 2.86CX Basic pKa: 3.46CX LogP: 6.40CX LogD: 3.60Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.16Np Likeness Score: -0.83
References 1. Lee T, Christov PP, Shaw S, Tarr JC, Zhao B, Veerasamy N, Jeon KO, Mills JJ, Bian Z, Sensintaffar JL, Arnold AL, Fogarty SA, Perry E, Ramsey HE, Cook RS, Hollingshead M, Davis Millin M, Lee KM, Koss B, Budhraja A, Opferman JT, Kim K, Arteaga CL, Moore WJ, Olejniczak ET, Savona MR, Fesik SW.. (2019) Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer., 62 (8): [PMID:30929420 ] [10.1021/acs.jmedchem.8b01991 ]